Latest biopharmaceutical Stories
MarketResearchReports.Biz announces addition of new report “Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells Industry Trend” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/the-engineered-t-cell-receptor-in-fusion-proteins-antibodies-and-cells-emerging-opportunities-for-the-biopharmaceutical-industry. Albany, NY (PRWEB) October 24, 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities...
It’s not the first prediction that has been made about the market for generic forms of biopharmaceutical drugs, but according to Kalorama Information a multi-billion dollar market for biosimilars will arrive in the next five years. The healthcare organization says it’s in almost everyone’s interest - payors, governments, providers and patients seeking low-cost alternatives to the most expensive and effective therapies. New York, NY (PRWEB) October 16, 2013 It’s not the first...
- Remarkable; prodigious.
- Audacious; gutsy.
- Completely; extremely.
- Audaciously; boldly.
- Impressively great in size; enormous; extraordinary.